Gender Heterogeneity in the Influencing Factors for Cerebral Microbleeds in Acute Ischemic Stroke Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 18 years and older
- Must meet the diagnostic criteria for AIS as presented in the Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2014
- Must be in good physical condition and have the ability to cooperate with MRI examinations
- Must have underwent SWI
Exclusion Criteria:
- MRI contraindications present, such as cardiac pacemaker, cardiac stents, or metal implants
- Head MRI or carotid artery ultrasound suggests the presence of severe stenosis or occlusion in the intracranial or extracranial segments of the cerebral arteries
- Severe comorbid diseases, such as cardiac, pulmonary, hepatic, and renal insufficiencies
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Comparison of clinical data between AIS patients in CMB and non-CMB groups
|
|
|
without CMBs; with CMBs
|
Whether patients with acute ischemic stroke are complicated by cerebral microbleeds
|
|
male; female
|
Whether patients with acute ischemic stroke are complicated by cerebral microbleeds
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of clinical data between AIS patients in CMB and non-CMB groups
Time Frame: from January 2014 to December 2015
|
Differences in general information between AIS patients in CMB and non-CMB groups
|
from January 2014 to December 2015
|
|
Comparison of clinical data between male and female AIS patients
Time Frame: from January 2014 to December 2015
|
Differences in general informationbetween male and female AIS patients
|
from January 2014 to December 2015
|
|
Comparison of CMB-related characteristics between the male and female AIS patients
Time Frame: from January 2014 to December 2015
|
Differences in CMB-related characteristics between the male and female AIS patients
|
from January 2014 to December 2015
|
|
Predictive factor analysis for CMBs in male AIS patients
Time Frame: from January 2014 to December 2015
|
CMB-related factors in male AIS patients
|
from January 2014 to December 2015
|
|
Predictive factor analysis for CMBs in female AIS patients
Time Frame: from January 2014 to December 2015
|
CMB-related factors in female AIS patients
|
from January 2014 to December 2015
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20220642
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.